{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T21:10:46Z","timestamp":1778101846174,"version":"3.51.4"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales de Pathologie"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.annpat.2026.04.001","type":"journal-article","created":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T20:15:16Z","timestamp":1778098516000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Lymphome B diffus \u00e0 grandes cellules-NOS, lymphomes B de haut grade et lymphome de Burkitt\u00a0: actualit\u00e9s"],"prefix":"10.1016","author":[{"given":"Maxence","family":"Rauturier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Ling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annick","family":"Chauvel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fanny","family":"Beltzung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie","family":"Parrens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.annpat.2026.04.001_bib0385","volume":"11","author":"Rosenwald","year":"2024"},{"key":"10.1016\/j.annpat.2026.04.001_bib0390","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1080\/10428190210173","article-title":"Diffuse large B-cell lymphoma: a clinicopathologic analysis of 444\u00a0cases classified according to the updated Kiel classification","volume":"43","author":"Diebold","year":"2002","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.annpat.2026.04.001_bib0395","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1056\/NEJMra2027612","article-title":"Diffuse large B-cell lymphoma","volume":"384","author":"Sehn","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.annpat.2026.04.001_bib0400","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1365-2559.2010.03696.x","article-title":"Epidemiology of lymphomas","volume":"58","author":"Roman","year":"2011","journal-title":"Histopathology"},{"key":"10.1016\/j.annpat.2026.04.001_bib0405","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1200\/JCO.2010.33.3419","article-title":"Impact of concordant and discordant bone marrow involvement on outcome in diffuse large B-cell lymphoma treated with R-CHOP","volume":"29","author":"Sehn","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.annpat.2026.04.001_bib0410","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/jncimonographs\/lgu010","article-title":"Medical history, lifestyle, family history, and occupational risk factors for diffuse large B-cell lymphoma: the InterLymph Non-Hodgkin Lymphoma Subtypes Project","volume":"2014","author":"Cerhan","year":"2014","journal-title":"J Natl Cancer Inst Monogr"},{"key":"10.1016\/j.annpat.2026.04.001_bib0415","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/nri3804","article-title":"Dynamics of B cells in germinal centres","volume":"15","author":"De Silva","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.annpat.2026.04.001_bib0420","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.3389\/fimmu.2018.02026","article-title":"The transcriptional regulation of germinal center formation","volume":"9","author":"Song","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.annpat.2026.04.001_bib0425","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/35000501","article-title":"Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling","volume":"403","author":"Alizadeh","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.annpat.2026.04.001_bib0430","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1053\/j.seminhematol.2015.01.005","article-title":"The genetic landscape of diffuse large B-cell lymphoma","volume":"52","author":"Pasqualucci","year":"2015","journal-title":"Semin Hematol"},{"key":"10.1016\/j.annpat.2026.04.001_bib0435","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1182\/bloodadvances.2018023572","article-title":"High-resolution architecture and partner genes of MYC rearrangements in lymphoma with DLBCL morphology","volume":"2","author":"Chong","year":"2018","journal-title":"Blood Adv"},{"key":"10.1016\/j.annpat.2026.04.001_bib0440","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1038\/s41375-019-0691-6","article-title":"Distinct genetic changes reveal evolutionary history and heterogeneous molecular grade of DLBCL with MYC\/BCL2\u00a0double-hit","volume":"34","author":"Cucco","year":"2020","journal-title":"Leukemia"},{"key":"10.1016\/j.annpat.2026.04.001_bib0445","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.cell.2017.09.027","article-title":"Genetic and functional drivers of diffuse large B\u00a0cell lymphoma","volume":"171","author":"Reddy","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.annpat.2026.04.001_bib0450","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1056\/NEJMoa1801445","article-title":"Genetics and pathogenesis of diffuse large B-cell lymphoma","volume":"378","author":"Schmitz","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.annpat.2026.04.001_bib0455","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/s41591-018-0016-8","article-title":"Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes","volume":"24","author":"Chapuy","year":"2018","journal-title":"Nat Med"},{"key":"10.1016\/j.annpat.2026.04.001_bib0460","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1080\/10428190210173","article-title":"Diffuse large B-cell lymphoma: a clinicopathologic analysis of 444\u00a0cases classified according to the updated Kiel classification","volume":"43","author":"Diebold","year":"2002","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.annpat.2026.04.001_bib0465","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/PAS.0000000000000319","article-title":"Diffuse large B-cell lymphomas of immunoblastic type are a major reservoir for MYC-IGH translocations","volume":"39","author":"Horn","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.annpat.2026.04.001_bib0470","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1053\/j.seminhematol.2015.01.006","article-title":"The histological classification of diffuse large B-cell lymphomas","volume":"52","author":"Xie","year":"2015","journal-title":"Semin Hematol"},{"key":"10.1016\/j.annpat.2026.04.001_bib0475","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1038\/s41379-020-00685-7","article-title":"The clinicopathological and molecular features of sinusoidal large B-cell lymphoma","volume":"34","author":"Xu","year":"2021","journal-title":"Mod Pathol"},{"key":"10.1016\/j.annpat.2026.04.001_bib0480","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/modpathol.3880041","article-title":"Sinusoidal CD30-positive large B-cell lymphoma: a morphologic mimic of anaplastic large cell lymphoma","volume":"13","author":"Lai","year":"2000","journal-title":"Mod Pathol"},{"key":"10.1016\/j.annpat.2026.04.001_bib0485","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1097\/PAS.0000000000000836","article-title":"Anaplastic variant of diffuse large B-cell lymphoma displays intricate genetic alterations and distinct biological features","volume":"41","author":"Li","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.annpat.2026.04.001_bib0490","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1182\/blood-2003-05-1545","article-title":"Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray","volume":"103","author":"Hans","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.annpat.2026.04.001_bib0495","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1097\/PAI.0000000000000843","article-title":"Comparison of the Lymph2Cx assay and Hans algorithm in determining the cell-of-origin of diffuse large B-cell lymphomas, not otherwise specified","volume":"28","author":"Cho","year":"2020","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1016\/j.annpat.2026.04.001_bib0500","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/ajh.25666","article-title":"Cell-of-origin determined by both gene expression profiling and immunohistochemistry is the strongest predictor of survival in patients with diffuse large B-cell lymphoma","volume":"95","author":"Abdulla","year":"2020","journal-title":"Am J Hematol"},{"key":"10.1016\/j.annpat.2026.04.001_bib0505","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.ccell.2020.03.015","article-title":"A probabilistic classification tool for genetic subtypes of diffuse large B cell lymphoma with therapeutic implications","volume":"37","author":"Wright","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.annpat.2026.04.001_bib0510","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1182\/blood-2012-06-435842","article-title":"MYC status in concert with BCL2\u00a0and BCL6\u00a0expression predicts outcome in diffuse large B-cell lymphoma","volume":"121","author":"Horn","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.annpat.2026.04.001_bib0515","doi-asserted-by":"crossref","first-page":"3452","DOI":"10.1200\/JCO.2011.41.0985","article-title":"Concurrent expression of MYC and BCL2\u00a0in diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone","author":"Johnson","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.annpat.2026.04.001_bib0520","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1182\/blood.V99.3.815","article-title":"De novo CD5+ diffuse large B-cell lymphoma: a clinicopathologic study of 109\u00a0patients","volume":"99","author":"Yamaguchi","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.annpat.2026.04.001_bib0525","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1111\/j.1365-2559.2012.04260.x","article-title":"SOX11\u00a0is useful in differentiating cyclin D1-positive diffuse large B-cell lymphoma from mantle cell lymphoma","volume":"61","author":"Hsiao","year":"2012","journal-title":"Histopathology"},{"key":"10.1016\/j.annpat.2026.04.001_bib0530","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1080\/1354750X.2019.1691656","article-title":"Clinicopathologic features and prognostic significance of CD30\u00a0expression in de novo diffuse large B-cell lymphoma (DLBCL): results in a homogeneous series from a single institution","volume":"25","author":"Salas","year":"2020","journal-title":"Biomarkers"},{"key":"10.1016\/j.annpat.2026.04.001_bib0535","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1182\/bloodadvances.2021004515","article-title":"Clinicopathological features and survival in EBV-positive diffuse large B-cell lymphoma not otherwise specified","volume":"5","author":"Bourbon","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.annpat.2026.04.001_bib0540","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1182\/blood-2015-05-647602","article-title":"MYC-IG rearrangements are negative predictors of survival in DLBCL patients treated with immunochemotherapy: a GELA\/LYSA study","volume":"126","author":"Copie-Bergman","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.annpat.2026.04.001_bib0545","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/cjp2.10","article-title":"The prognosis of MYC translocation positive diffuse large B-cell lymphoma depends on the second hit","volume":"1","author":"Clipson","year":"2015","journal-title":"J Pathol Clin Res"},{"key":"10.1016\/j.annpat.2026.04.001_bib0550","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1182\/blood.2019002699","article-title":"Distinct molecular profile of IRF4-rearranged large B-cell lymphoma","volume":"135","author":"Ramis-Zaldivar","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.annpat.2026.04.001_bib0555","doi-asserted-by":"crossref","first-page":"2848","DOI":"10.1200\/JCO.2014.60.2383","article-title":"Prognostic significance of diffuse large B-cell lymphoma cell of origin determined by digital gene expression in formalin-fixed paraffin-embedded tissue biopsies","volume":"33","author":"Scott","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.annpat.2026.04.001_bib0560","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S1470-2045(18)30935-5","article-title":"Gene-expression profiling of bortezomib added to standard chemoimmunotherapy for diffuse large B-cell lymphoma (REMoDL-B): an open-label, randomised, phase 3\u00a0trial","volume":"20","author":"Davies","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.annpat.2026.04.001_bib0565","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: lymphoid neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia"},{"key":"10.1016\/j.annpat.2026.04.001_bib0570","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1182\/blood.2022015851","article-title":"The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee","volume":"140","author":"Campo","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.annpat.2026.04.001_bib0575","volume":"11","author":"Leoncini","year":"2024"},{"key":"10.1016\/j.annpat.2026.04.001_bib0580","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s00428-017-2199-7","article-title":"The clinicopathologic spectrum of mature aggressive B cell lymphomas","volume":"471","author":"Rimsza","year":"2017","journal-title":"Virchows Arch"},{"key":"10.1016\/j.annpat.2026.04.001_bib0585","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1182\/blood.2020008374","article-title":"Defining and treating high-grade B-cell lymphoma, NOS","volume":"140","author":"Olszewski","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.annpat.2026.04.001_bib0590","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/s41375-022-01778-9","article-title":"High-grade B-cell lymphoma (HGBL)-NOS is clinicopathologically and genetically more similar to DLBCL\/HGBL-DH than DLBCL","volume":"37","author":"Li","year":"2023","journal-title":"Leukemia"},{"key":"10.1016\/j.annpat.2026.04.001_bib0595","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1097\/PAS.0000000000000818","article-title":"Further exploration of the complexities of large B-cell lymphomas with MYC abnormalities and the importance of a blastoid morphology","volume":"41","author":"Moore","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.annpat.2026.04.001_bib0600","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s00428-021-03050-4","article-title":"The \u201cBurkitt-like\u201d immunophenotype and genotype is rarely encountered in diffuse large B cell lymphoma and high-grade B cell lymphoma, NOS","volume":"479","author":"H\u00fcttl","year":"2021","journal-title":"Virchows Arch"},{"key":"10.1016\/j.annpat.2026.04.001_bib0605","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1080\/17474086.2018.1494567","article-title":"Advances in pathological understanding of high-grade B cell lymphomas","volume":"11","author":"Li","year":"2018","journal-title":"Expert Rev Hematol"},{"key":"10.1016\/j.annpat.2026.04.001_bib0610","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1182\/blood-2018-07-864025","article-title":"The mutational landscape of Burkitt-like lymphoma with 11q aberration is distinct from that of Burkitt lymphoma","volume":"133","author":"Wagener","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.annpat.2026.04.001_bib0615","volume":"11","author":"Tooze","year":"2024"},{"key":"10.1016\/j.annpat.2026.04.001_bib0620","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/ajh.26068","article-title":"First-line treatment of double-hit and triple-hit lymphomas: survival and tolerance data from a retrospective multicenter French study","volume":"96","author":"Laude","year":"2021","journal-title":"Am J Hematol"},{"key":"10.1016\/j.annpat.2026.04.001_bib0625","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/modpathol.2011.147","article-title":"B-cell lymphomas with MYC\/8q24\u00a0rearrangements and IGH@BCL2\/t(14;18)(q32;q21): an aggressive disease with heterogeneous histology, germinal center B-cell immunophenotype and poor outcome","volume":"25","author":"Li","year":"2012","journal-title":"Mod Pathol"},{"key":"10.1016\/j.annpat.2026.04.001_bib0630","doi-asserted-by":"crossref","first-page":"3359","DOI":"10.1200\/JCO.19.00743","article-title":"Prognostic significance of MYC rearrangement and translocation partner in diffuse large B-cell lymphoma: a study by the Lunenburg lymphoma biomarker consortium","volume":"37","author":"Rosenwald","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.annpat.2026.04.001_bib0635","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1182\/blood-2017-12-820605","article-title":"High-grade B-cell lymphoma with MYC and BCL2\u00a0and\/or BCL6\u00a0rearrangements with diffuse large B-cell lymphoma morphology","volume":"131","author":"Scott","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.annpat.2026.04.001_bib0640","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.3324\/haematol.11305","article-title":"The clinical presentation and prognosis of diffuse large B-cell lymphoma with t(14;18) and 8q24\/c-MYC rearrangement","volume":"92","author":"Le Gouill","year":"2007","journal-title":"Haematologica"},{"key":"10.1016\/j.annpat.2026.04.001_bib0645","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1200\/JCO.18.01583","article-title":"Double-hit gene expression signature defines a distinct subgroup of germinal center B-cell-like diffuse large B-cell lymphoma","volume":"37","author":"Ennishi","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.annpat.2026.04.001_bib0650","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1200\/JCO.18.01314","article-title":"Molecular high-grade B-cell lymphoma: defining a poor-risk group that requires different approaches to therapy","volume":"37","author":"Sha","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.annpat.2026.04.001_bib0655","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/PAS.0b013e31826cebad","article-title":"Double-hit B-cell lymphomas with BCL6\u00a0and MYC translocations are aggressive, frequently extranodal lymphomas distinct from BCL2\u00a0double-hit B-cell lymphomas","volume":"37","author":"Pillai","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.annpat.2026.04.001_bib0660","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1182\/blood-2010-09-297879","article-title":"Double-hit B-cell lymphomas","volume":"117","author":"Aukema","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.annpat.2026.04.001_bib0665","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1038\/s41379-018-0067-x","article-title":"MYC\/BCL2\/BCL6\u00a0triple hit lymphoma: a study of 40\u00a0patients with a comparison to MYC\/BCL2\u00a0and MYC\/BCL6\u00a0double hit lymphomas","volume":"31","author":"Huang","year":"2018","journal-title":"Mod Pathol"},{"key":"10.1016\/j.annpat.2026.04.001_bib0670","volume":"11","author":"Klapper","year":"2024"},{"key":"10.1016\/j.annpat.2026.04.001_bib0675","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.3324\/haematol.2018.207928","article-title":"Burkitt-like lymphoma with 11q aberration: a germinal center-derived lymphoma genetically unrelated to Burkitt lymphoma","volume":"104","author":"Gonzalez-Farre","year":"2019","journal-title":"Haematologica"},{"key":"10.1016\/j.annpat.2026.04.001_bib0680","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1182\/blood-2013-06-507996","article-title":"A recurrent 11q aberration pattern characterizes a subset of MYC-negative high-grade B-cell lymphomas resembling Burkitt lymphoma","volume":"123","author":"Salaverria","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.annpat.2026.04.001_bib0685","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1097\/PAS.0000000000001613","article-title":"A Diagnostic approach to the identification of Burkitt-like lymphoma with 11q aberration in aggressive B-cell lymphomas","volume":"45","author":"Horn","year":"2021","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.annpat.2026.04.001_bib0690","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/modpathol.2017.186","article-title":"A comprehensive flow-cytometry-based immunophenotypic characterization of Burkitt-like lymphoma with 11q aberration","volume":"31","author":"Rymkiewicz","year":"2018","journal-title":"Mod Pathol"},{"key":"10.1016\/j.annpat.2026.04.001_bib0695","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/ajcp\/aqx139","article-title":"The 11q-gain\/loss aberration occurs recurrently in MYC-negative Burkitt-like lymphoma with 11q aberration, as well as MYC-positive Burkitt lymphoma and MYC-positive high-grade B-Cell lymphoma, NOS","volume":"149","author":"Grygalewicz","year":"2017","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.annpat.2026.04.001_bib0700","volume":"11","author":"Sayed","year":"2024"},{"key":"10.1016\/j.annpat.2026.04.001_bib0705","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1182\/blood-2018-04-844472","article-title":"How I treat Burkitt lymphoma in children, adolescents, and young adults in sub-Saharan Africa","volume":"132","author":"Gopal","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.annpat.2026.04.001_bib0710","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s13244-019-0733-7","article-title":"An update on Burkitt lymphoma: a review of pathogenesis and multimodality imaging assessment of disease presentation, treatment response, and recurrence","volume":"10","author":"Kalisz","year":"2019","journal-title":"Insights Imaging"},{"key":"10.1016\/j.annpat.2026.04.001_bib0715","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1158\/1541-7786.MCR-16-0305","article-title":"Comprehensive transcriptome and mutational profiling of endemic Burkitt lymphoma reveals EBV type-specific differences","volume":"15","author":"Kaymaz","year":"2017","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.annpat.2026.04.001_bib0720","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1182\/blood-2005-01-0168","article-title":"Immunoglobulin gene analysis reveals 2\u00a0distinct cells of origin for EBV-positive and EBV-negative Burkitt lymphomas","volume":"106","author":"Bellan","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.annpat.2026.04.001_bib0725","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1182\/blood.2019001880","article-title":"The whole-genome landscape of Burkitt lymphoma subtypes","volume":"134","author":"Panea","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.annpat.2026.04.001_bib0730","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/nature11378","article-title":"Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics","volume":"490","author":"Schmitz","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.annpat.2026.04.001_bib0735","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1038\/ng.2469","article-title":"Recurrent mutation of the ID3\u00a0gene in Burkitt lymphoma identified by integrated genome, exome and transcriptome sequencing","volume":"44","author":"Richter","year":"2012","journal-title":"Nat Genet"},{"key":"10.1016\/j.annpat.2026.04.001_bib0740","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/bjh.17922","article-title":"Epstein-Barr virus positivity as a defining pathogenetic feature of Burkitt lymphoma subtypes","volume":"196","author":"Leoncini","year":"2022","journal-title":"Br J Haematol"},{"key":"10.1016\/j.annpat.2026.04.001_bib0745","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1182\/blood.V93.3.1124","article-title":"Burkitt's lymphoma: a single disease with multiple variants. The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues","volume":"93","author":"Jaffe","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.annpat.2026.04.001_bib0750","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1111\/j.1365-2141.2011.08771.x","article-title":"Diagnosis of Burkitt lymphoma using an algorithmic approach\u00a0\u2013\u00a0applicable in both resource-poor and resource-rich countries","volume":"154","author":"Naresh","year":"2011","journal-title":"Br J Haematol"},{"key":"10.1016\/j.annpat.2026.04.001_bib0755","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1200\/JCO.20.03288","article-title":"Burkitt Lymphoma International Prognostic Index","volume":"39","author":"Olszewski","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.annpat.2026.04.001_bib0380","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s11912-020-0898-8","article-title":"Burkitt and Burkitt-like lymphomas: a systematic review","volume":"22","author":"Saleh","year":"2020","journal-title":"Curr Oncol Rep"}],"container-title":["Annales de Pathologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0242649826000660?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0242649826000660?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T20:15:24Z","timestamp":1778098524000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0242649826000660"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":76,"alternative-id":["S0242649826000660"],"URL":"https:\/\/doi.org\/10.1016\/j.annpat.2026.04.001","relation":{},"ISSN":["0242-6498"],"issn-type":[{"value":"0242-6498","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lymphome B diffus \u00e0 grandes cellules-NOS, lymphomes B de haut grade et lymphome de Burkitt\u00a0: actualit\u00e9s","name":"articletitle","label":"Article Title"},{"value":"Annales de Pathologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annpat.2026.04.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}